Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange Arca · Sector Equity
$54.14
−$0.3232 · -0.59%
· Aug 24, 1:57 PM ET
$54.14
Regular session−$0.3232 · -0.59%
· Aug 24, 1:57 PM ET
$54.14
−$0.3232 · -0.59%
Regular session · ET · Market data may be delayed.
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Fund assets
51.68M USD
Expense ratio
0.65%
NAV
$54.40
Average volume
24.43K
Volume
11.11K
Day range
$52.81 – $54.62
52-week range
$22.43 – $56.18
Previous close
$54.4632
Price change
1 day
-0.59%
1 month
+9.00%
3 months
+26.76%
Year to date
+40.40%
1 year
+140.84%
3 years
+154.30%
5 years
+17.90%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 24, 2026.
Portfolio composition
Latest coverage
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
